|
|
|
|
REFERENCES
Boice JD Jr, Greene MH, Keehn RJ, et al.: Late effects of
low-dose adjuvant chemotherapy in colorectal cancer.
J Natl Cancer Inst 64:501-511, 1980. Boice JD Jr, Greene MH, Killen JY, et al.: Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU). N Engl J Med 309:1079-1084, 1983. Chak LY, Sikic BI, Tucker MA, et al.: Increased incidence
of acute nonlymphocytic leukemia following therapy
in patients with small cell carcinoma of the lung.
J Clin Oncol 2:385-390, 1984. Curtis RE, Boice JD Jr, Moloney WC, et al.: Leukemia
following chemotherapy for breast cancer. Cancer Res 50:2741-2746, 1990. Fisher B, Rockette H, Fisher E, et al.: Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J Clin Oncol 3:1640-1658, 1985. Greene MH, Boice JD Jr, Greer GE, et al.: Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer. N Engl J Med 307:1416-1421, 1982. Greene MH, Boice JD Jr, and Strike TA: Carmustine as a cause of acute nonlymphocytic leukemia. N Engl J Med 313:579, 1985. Greene MH, Harris EL, Gershenson DM, et al.: Melphalan may be a more potent leukemogen than cyclophosphamide. Ann Intern Med 105:360-367, 1986. Greene MH, Young RC, Merrill JR, et al.: Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma. Cancer Res 43:1891-1898, 1983. Kaldor JM, Day NE, Clarke EA, et al.: Leukemia following Hodgkin's disease. N Engl J Med 322:7-13, 1990. LeBeau M, Albain KS, Larson RA, et al.: Clinical and
cytogenetic correlation in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol
4:325-345, 1986. Pedersen-Bjergaard J, Ersboll J, Hansen VL, et al.: Carcinoma of the urinary bladder after treatment
with cyclophosphamide for non-Hodgkin's lymphoma.
N Engl J Med 318:1028-32, 1988. Pedersen-Bjergaard JP, Osterlind K, Hansen M, et al.: Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small-cell carcinoma of the lung. Blood 66:1393-1397, 1985. Pui C-H, Behm FG, Raimondi SC, et al.: Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 321:136-142, 1990. Ratain MJ, Kaminer LS, Bitran JD, et al.: Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood 70:1412-1417, 1987. Tucker MA, Coleman CN, Cox RS, et al.: Risk of second malignancies following Hodgkin's disease after 15 years. N Engl J Med 318:76-81, 1988. Tucker MA, D'Angio GJ, Boice JD Jr, et al.: Bone sarcoma linked to radiotherapy and chemotherapy in children.
N Engl J Med 317:588-593, 1987a. Tucker MA, Meadows AT, Boice JD Jr, et al.: Leukemia after therapy with alkylating agents for childhood cancer.
J Natl Cancer Inst 78:459-464, 1987b. Valagussa P: Second malignancies: the experience of
the Milan Cancer Institute. J Cancer Res Clin Oncol
116 [Suppl]:982, 1990. Valagussa P, Santoro A, Fossati-Bellani F, et al.: Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 4:830-837, 1986. Van Leeuwen FE, Somers R, Taal BG, et al.: Increased
risk of lung cancer, non- Hodgkin's lymphoma,
and leukemia following Hodgkin's disease.
J Clin Oncol 7:1046-1058, 1989. |
